Hospital-acquired Infections Market Analysis, Key Players, Growth, Size

Posted by Sapana on March 25th, 2020

Hospital-acquired Infections Market Overview

Hospital-acquired infections (HAI) are those which are inherited by a person in a healthcare facility from another patient or an infected staff. They are excluded from the one that the patient was already suffering from before being admitted to a healthcare facility. HIA is also inclusive of occupational infection found among hospital staff. Market Research Future (MRFR) has recently published a report on the global hospital-acquired infections market analysis and has asserted that the market is likely to reach USD 36.16 Bn at a CAGR of 7.3% by the end of the forecast period of 2017-2022.

Although healthcare facilities across the globe are equipped with robust disinfecting technologies, infections still continue to prevail. Sometimes, microorganisms originate from a patient's own skin microbiota after surgeries. The factors driving the growth of the global hospital-acquired infections market include nature and virulence of the microbial agent, poor infection control practices among healthcare organizations, crowding, high bacterial load in hospitals due to the presence of infected materials, and environmental factors such as temperature and humidity where bacteria can thrive.

A rise in geriatric population who suffer from chronic diseases and stay for prolonged periods in hospitals also boost the growth of the market. The elderly population is generally more prone to acquiring life-threatening diseases as they have a weak immune response. The hospital-acquired infections market is likely to gain growth opportunities from advancement in technologies such as gas plasma sterilization technology. The hospital-acquired infections market is thriving in developing and underdeveloped economies. These regions have poor healthcare infrastructure, and the level of awareness regarding health and hygiene is generally low in healthcare institutions. Moreover, lack of proper disinfection technologies in hospitals also favors the growth of the market.

On the downside, the market growth of hospital-acquired infections is constrained by microbial resistance, increasing the use of disposables, usage of disease inhibiting materials in hospitals such as ceramics and glass, and huge fragmentation of the market. Additionally, stringent regulations aimed at curbing hospital-acquired infections also constrain the growth of the market. 

Hospital-acquired Infections Market Segmentation

The hospital-acquired infections market has been segmented based on pathogen type, method of treatment, and infection type.

By pathogen type, the hospital-acquired infections market has been segmented into viral, bacterial, and fungal.

By method of treatment, the hospital-acquired infections market has been segmented into sterilization, chemical, radiation.

By infection type, the hospital-acquired infections market has been segmented into urinary tract infections, bloodstream infections, surgical site infections, gastrointestinal infections, and respiratory infections.

Hospital-acquired Infections Market Regional Analysis

Region-wise, the hospital-acquired infections market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The Americas account for the foremost share of the global hospital-acquired infections market followed by Europe. The Americas market is anticipated to reach USD 12 Bn by 2022. The APAC is likely to capture the highest CAGR over the forecast period. The developing economies of the region lack [roper healthcare infrastructure, which gives way to the prevalence of HIA in the region. Moreover, the level of awareness regarding hygiene is also considerably low in these developing countries, which further support the growth of the market.

Hospital-acquired Infections Market Competitive Landscape

Advanced Sterilization Products, Belimed AG, Cantel Medical Corp., 3M Company, Getinge AB, Becton Dickinson and company, and STERIS Corporation are the notable players in the global hospital-acquired infections market.

Browse Complete Report with TOC at

Hospital-acquired Infections Industry Updates

July 2019 - Day Zero Diagnostics, a high-tech diagnostic company, received a Phase I Small Business Innovation Research award from Infectious Disease of the National Institutes of Health and the National Institute of Allergies. The company intends to use the fund for the development of Ksim, an algorithm which automatically detects hospital-acquired infection outbreaks. Ksim is a high-resolution, faster, and more scalable approach for identification of hospital-acquired infections using data gathered from hospitals publications and large datasets available from various hospitals.

Like it? Share it!


About the Author

Joined: March 13th, 2019
Articles Posted: 270

More by this author